RobertIsraelMD

PubMed

• 2 citations
  Central venous catheter complications in sarcoma patients receiving adjuvant chemotherapy
  Robert J. Israel, Cordon B. Magill, Murray F. Brennan> ;Journal of Surgical Oncology. 1990 Jun 1
• 19 citations
  Metoclopramide decreases renal plasma flow
  Robert Israel, Vivian O'Mara, Beth Austin, Alessandro Bellucci, B. Robert Meyer> ;Clinical Pharmacology and Therapeutics. 1986 Mar 1
• 113 citations
  Gallium nitrate for acute treatment of cancer-related hypercalcemia. A randomized, double-blind comparison to calcitonin.
  Raymond P. Warrell, Robert Israel, Marianne Frisone, Teresa Snyder, Jeffrey J. Gaynor, Richard S. Bockman> ;Annals of Internal Medicine. 1988 May 1
• 23 citations
  Treatment of neutropenia associated with dyskeratosis congenita with granulocyte-macrophage colony-stimulating factor
  CarolynL. Russo, BertilE. Glader, RobertJ. Israel, Frank L. Galasso> ;Lancet. 1990 Sep 22
• Low Dose Interferon Alfa-2B for the Induction of Remission of Hairy Cell Leukemia: A Multi-institutional Study of 49 Patients.
  Harvey M. Golomb, Mark J. Ratain, A. Fefer, J. Thompson, C. S. Portlock, Howard Ozer, Rosemarie Mick, J. Chiavello, R. J. Israel, E. M. Bonnem> ;Leukemia & Lymphoma. 1991 Jan 1
• Granulocyte-macrophage colony-stimulating factor and azidothymidine in patients with acquired immunodeficiency syndrome [letter; comment]
  RJ Israel, JD Levine> ;Blood. 1991 May 1
• 39 citations
  Recombinant human granulocyte-macrophage colony-stimulating factor ameliorates zidovudine-induced neutropenia in patients with acquired immunodeficiency syndrome (AIDS...
  James D. Levine, J D Allan, JH Tessitore, N Falcone, F Galasso, RJ Israel, Jerome E. Groopman> ;Blood. 1991 Dec 15
• 77 citations
  Induction of Antibodies against GM2 Ganglioside by Immunizing Melanoma Patients Using GM2-Keyhole Limpet Hemocyanin + QS21 Vaccine: A Dose-Response Study
  Paul B. Chapman, D. M. Morrissey, K. S. Panageas, W. B. Hamilton, C. Zhan, Alicia N. Destro, Lawrence J. Williams, R. J. Israel, P. O. Livingston> ;Clinical Cancer Research. 2000 Mar 1
• 42 citations
  Vaccination with a Bivalent GM2 and GD2 Ganglioside Conjugate Vaccine: A Trial Comparing Doses of GD2-Keyhole Limpet Hemocyanin
  Paul B. Chapman, Donna Morrisey, Katherine S. Panageas, Linda Williams, Jonathan J. Lewis, Robert J. Israel, W. Bradley Hamilton, Philip O. Livingston> ;Clinical Cancer Research. 2000 Dec 1
• 173 citations
  Dehydroascorbic acid, a blood–brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke
  Judy Huang, David B. Agus, Christopher J. Winfree, Szilard Kiss, William J. Mack, Ryan A McTaggart, Tanvir F. Choudhri, Louis J. Kim, J. Mocco, David J. Pinsky, Willia...> ;Proceedings of the National Academy of Sciences of the United States of America. 2001 Sep 25
• 84 citations
  Treatment of Advanced Human Immunodeficiency Virus Type 1 Disease with the Viral Entry Inhibitor PRO 542
  Jeffrey M. Jacobson, Robert J. Israel, Israel Lowy, Nancy A. Ostrow, Linda S. Vassilatos, Melanie Barish, Diep N. H. Tran, Brian M. Sullivan, Thomas J. Ketas, Tobias J...> ;Antimicrobial Agents and Chemotherapy. 2004 Feb 1
• 64 citations
  Tolerability, Gut Effects, and Pharmacokinetics of Methylnaltrexone Following Repeated Intravenous Administration in Humans
  Chun-Su Yuan, Harold Doshan, Martha R. Charney, Michael O'Connor, Theodore Karrison, Spring Maleckar, Robert J. Israel, Jonathan Moss> ;Journal of Clinical Pharmacology. 2005 May 1
• 42 citations
  Methylnaltrexone, a novel peripheral opioid receptor antagonist for the treatment of opioid side effects.
  Chun-Su Yuan, Robert J. Israel> ;Expert Opinion on Investigational Drugs. 2006 Apr 24
• 101 citations
  Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-rang...
  Russell K. Portenoy, Jay Thomas, Michele L. Moehl Boatwright, Diep N. H. Tran, Frank L. Galasso, Nancy Stambler, Charles F. von Gunten, Robert J. Israel> ;Journal of Pain and Symptom Management. 2008 May 1
• 326 citations
  Methylnaltrexone for Opioid-Induced Constipation in Advanced Illness
  Jay Thomas, Sloan Beth Karver, Gail Austin Cooney, Bruce H. Chamberlain, Charles Kevin Watt, Neal E. Slatkin, Nancy Stambler, Alton B. Kremer, Robert J. Israel> ;The New England Journal of Medicine. 2008 May 29
• 110 citations
  Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients.
  Neal E. Slatkin, Jay Thomas, Arthur G. Lipman, George Wilson, Michelle L. Boatwright, Charles V. Wellman, Donna S. Zhukovsky, Richard Stephenson, Russell K. Portenoy, ...> ;The Journal of Supportive Oncology. 2009 Jan 1
• 4 citations
  Methylnaltrexone potentiates body weight and fat reduction with leptin.
  Chun-Su Yuan, Shi Sun, Anoja S. Attele, Chong-Zhi Wang, BS Robin Tong, Robert J. Israel> ;Journal of Opioid Management. 2018 Jan 29
• 16 citations
  Methylnaltrexone for Opioid-Induced Constipation in Patients With Advanced Illness: A 3-Month Open-Label Treatment Extension Study
  Arthur G. Lipman, Sloan Beth Karver, Gail Austin Cooney, Nancy Stambler, Robert J. Israel> ;Journal of Pain & Palliative Care Pharmacotherapy. 2011 Jun 9
• 25 citations
  Characterization of Abdominal Pain During Methylnaltrexone Treatment of Opioid-Induced Constipation in Advanced Illness: A Post Hoc Analysis of Two Clinical Trials
  Neal E. Slatkin, Richard Lynn, Chinyu Su, Wenjin Wang, Robert J. Israel> ;Journal of Pain and Symptom Management. 2011 Nov 1
• 39 citations
  Rapid onset of action in patients with moderate-to-severe psoriasis treated with brodalumab: A pooled analysis of data from two phase 3 randomized clinical trials (AMA...
  Andrew Blauvelt, Kim A. Papp, Mark Lebwohl, Lawrence J. Green, Sylvia Hsu, Varsha Bhatt, Shipra Rastogi, Radhakrishnan Pillai, Robert Israel> ;Journal of the American Academy of Dermatology. 2017 Aug 1
• 18 citations
  Long-Term Safety and Efficacy of Subcutaneous Methylnaltrexone in Patients with Opioid-Induced Constipation and Chronic Noncancer Pain: A Phase 3, Open-Label Trial.
  Lynn R. Webster, Edward Michna, Arif Khan, Robert J Israel, Joseph R. Harper> ;Pain Medicine. 2017 Aug 1
• 1 citations
  Erratum to: Repeat Rifaximin for Irritable Bowel Syndrome: No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity (Digestive Diseases and Sciences...
  Mark Pimentel, Brooks D. Cash, Anthony Lembo, R. A. Wolf, R. J. Israel, Philip Schoenfeld> ;Digestive Diseases and Sciences. 2017 Oct 1
• 13 citations
  Safety and Efficacy of a Fixed Combination Halobetasol and Tazarotene Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Pooled Analysis of Two Phase 3 ...
  Jeffrey L Sugarman, Jonathan S. Weiss, Emil Tanghetti, Jerry Bagel, Paul S. Yamauchi, Stein Gold L, Tina Lin, Gina Martin, Radhakrishnan Pillai, Robert Israel> ;Journal of Drugs in Dermatology. 2018 Aug 1
• 1 citations
  Safety and Efficacy of a Once-Daily Halobetasol Propionate 0.01% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Results of Two Phase 3 Randomized Cont...
  Lawrence Green, Francisco A. Kerdel, Fran E Cook-Bolden, Jerry Bagel, Tina Lin, Gina Martin, Radhakrishnan Pillai, Robert Israel, Tage Ramakrishna> ;Journal of Drugs in Dermatology. 2018 Oct 1
• 23 citations
  Efficacy, Safety, and Patient-Reported Outcomes in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab for 5 Years in a Long-Term, Open-Label, Ph...
  Mark Lebwohl, Andrew Blauvelt, Alan Menter, Kim A. Papp, Scott Guenthner, Radhakrishnan Pillai, Robert Israel, Abby Jacobson> ;American Journal of Clinical Dermatology. 2019 Sep 6
• Join now to see all